SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016)

Autor: R. D. de Beveridge, A. Estival, Isabel Sevilla, J. Rubió, Virginia Martínez, D. Vicente, César Serrano, Andres Poveda, Javier Martin-Broto, M. J. Lecumberri
Přispěvatelé: [Poveda, A.] IVO, Inst Valenciano Oncol, Dept Med Oncol, Valencia, Spain, [Martinez, V.] Hosp Univ La Paz, Dept Med Oncol, Madrid, Spain, [Serrano, C.] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain, [Sevilla, I.] Hosp Univ Reg & Virgen de la Victoria Malaga, Inst Invest Biomed Malaga IBIMA, Invest Clin & Traslac Canc, Malaga, Spain, [Lecumberri, M. J.] Complejo Hosp Navarra, Dept Med Oncol, Navarra, MN, Spain, [de Beveridge, R. D.] Hosp Univ & Politecn La Fe, Dept Med Oncol, Musculoskeletal & Gastr Tumor Unit, Valencia, Spain, [Estival, A.] Hosp Badalona Germans Trias & Pujol, Inst Catalan Oncol, ICO Badalona, Dept Med Oncol, Badalona, Spain, [Vicente, D.] Hosp Univ Virgen Macarena, Dept Med Oncol, Badalona, Spain, [Rubio, J.] Hosp Josep Trueta, Inst Catalan Oncol, ICO Girona, Dept Med Oncol, Girona, Spain, [Martin-Broto, J.] Hosp Univ Virgen del Rocio, Dept Med Oncol, Av Manuel Siurot S-N, Seville 41013, Spain, [Martin-Broto, J.] Hosp Univ Virgen del Rocio, Inst Biomed, IBIS, Av Manuel Siurot S-N, Seville 41013, Spain
Rok vydání: 2016
Předmět:
Zdroj: CLINICAL & TRANSLATIONAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Digital.CSIC. Repositorio Institucional del CSIC
Clinical & Translational Oncology
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
ISSN: 1699-3055
1699-048X
DOI: 10.1007/s12094-016-1579-9
Popis: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the digestive tract, and this disease has served as a paradigmatic model for successful rational development of targeted therapies. The introduction of tyrosine kinase inhibitors with activity against KIT/PDGFRA in both localized and advanced stages has remarkably improved the survival in a disease formerly deemed resistant to all systemic therapies. The Spanish Society of Medical Oncology (SEOM) guidelines provide a multidisciplinary and updated consensus for the diagnosis and treatment of GIST patients. We strongly encourage that the managing of these patients should be performed within multidisciplinary teams in reference centers.
Databáze: OpenAIRE